Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02784626
Other study ID # B-1603/339-005
Secondary ID
Status Completed
Phase Phase 4
First received May 22, 2016
Last updated October 25, 2016
Start date May 2016
Est. completion date September 2016

Study information

Verified date October 2016
Source Seoul National University Bundang Hospital
Contact n/a
Is FDA regulated No
Health authority Republic of Korea: Seoul National University Bundang Hospital Institutional Review Board
Study type Interventional

Clinical Trial Summary

In this study, based on the hypothesis that dexmedetomidine administered intraoperatively for sedation can reduce postoperative pain than that of propofol, the investigators examined the ability of dexmedetomidine to reduce postoperative pain in in patients undergoing the total knee arthroplasty.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date September 2016
Est. primary completion date September 2016
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

- Patients undergoing total knee arthroplasty

- Age: 20 - 80 yrs

Exclusion Criteria:

- ASA classification = 3

- Patient who do not want sedation during the surgery

- Patient who wants general anesthesia

- Cardiovascular disease

- Liver dysfunction

- Renal dysfunction

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Intervention

Drug:
Dexmedetomidine
Intraoperative sedation using dexmedetomidine
Propofol
Intraoperative sedation using propofol

Locations

Country Name City State
Korea, Republic of Seoul National University Bundang Hospital Seongnam-si Gyeonggi-do

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Bundang Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Other Nausea and vomiting Incidence of nausea and vomiting during 24 hours postoperatively Postoperative 24 hours No
Other Nausea and vomiting Incidence of nausea and vomiting during 48 hours postoperatively Postoperative 48 hours No
Other Antiemetics Amount of antiemetics administered during 24 hours postoperatively Postoperative 24 hours No
Other Antiemetics Amount of antiemetics administered during 48 hours postoperatively Postoperative 48 hours No
Other Patient's satisfaction Patient's satisfaction with the pain management using a visual analogue scale (0 = very unsatisfied, 10 = completely satisfied) Postoperative 48 hours No
Primary Visual analogue scale Postoperative pain score at postoperative 24 hours Postoperative 24 hours No
Secondary Rescue analgesics Amount of rescue analgesics administered during 24 hours postoperatively Postoperative 24 hours No
Secondary Rescue analgesics Amount of rescue analgesics administered during 48 hours postoperatively Postoperative 48 hours No
Secondary Visual analogue scale Postoperative pain score at postoperative 48 hours Postoperative 48 hours No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04525950 - Robotized Navigation Compared to Conventional Technique in Total Knee Replacement N/A
Active, not recruiting NCT03312465 - Anatomical Shoulder Domelock System Study
Recruiting NCT03260465 - Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup N/A
Active, not recruiting NCT02154516 - Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System N/A
Completed NCT02967874 - Autologous Adipose-Derived Stromal Vascular Fraction Cells for Osteoarthritis Treatment Phase 1/Phase 2
Withdrawn NCT02341079 - Intraoperative Liposomal Bupivacaine Injection in Primary Total Knee Arthroplasty Phase 2/Phase 3
Terminated NCT03245320 - Clinical Evaluation of the TITAN™ Total Shoulder System
Recruiting NCT03958370 - Validation of Consumer Activity Monitors in Postoperative Total Arthroplasty Patients
Recruiting NCT06080412 - Blueprint® Mixed Reality Pilot Study
Active, not recruiting NCT03631030 - Cooled RF Lesion MRI Characteristics N/A
Withdrawn NCT02799654 - Excia T Cementless EBRA Study N/A
Completed NCT00105677 - Understanding the Differences in the Management of Patients With Arthritis of the Knee or Hip N/A
Terminated NCT02435420 - A Retro-prospective Study of Total Hip Arthroplasty With EMPERION Modular Primary Stem in Australian Centres (HISTORIC) N/A
Completed NCT03142178 - 3VM for Treatment of Chronic Osteoarthritis Knee Pain Phase 1/Phase 2
Completed NCT02276833 - Use of Autologous Adipose-Derived Stromal Vascular Fraction to Treat Osteoarthritis of the Knee Phase 1